Isoniazid-related fatal hepatitis

Western Journal of Medicine

Volumn 164, Issue 6, 1996, Pages 486-491

  Millard, Peter S ^a   Wilcosky, Timothy C ^b   Reade Christopher, Susan J ^b   Weber, David J ^c  

^a EASTERN MAINE MEDICAL CENTER   (United States)

^b RTI INTERNATIONAL   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; DRUG MONITORING; FATALITY; FEMALE; HEPATITIS; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; PATIENT EDUCATION; PATIENT SELECTION; TUBERCULOSIS;

ADOLESCENT; ADULT; AGED; ANTITUBERCULAR AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; HEPATITIS, TOXIC; HUMANS; INCIDENCE; ISONIAZID; MALE; MIDDLE AGED; RISK; SURVIVAL RATE; TUBERCULOSIS;

EID: 0029893969     PISSN: 00930415     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Ferebee SH, Mount FW: Tuberculosis morbidity in a controlled trial of the prophylactic use of isoniazid among household contacts. Am Rev Respir Dis 1962; 85:490-510
2. Ferebee SH, Mount FW, Murray FJ, Livesay VT: A controlled trial of isoniazid prophylaxis in mental institutions. Am Rev Respir Dis 1963; 88:161-175
3. Comstock GW, Ferebee SH, Hammes LM: A controlled trial of community-wide isoniazid prophylaxis in Alaska. Am Rev Respir Dis 1967; 95:935-943
4. Merrit AD, Fetter BF: Toxic hepatic necrosis (hepatitis) due to isoniazid: Report of a case with cirrhosis and death due to hemorrhage from esophageal varices. Ann Intern Med 1959; 50:804-810
5. Maddrey WC, Boitnott JK: Isoniazid hepatitis. Ann Intern Med 1973; 79: 1-12
6. Black M, Mitchell JR, Zimmerman HJ, Ishak KG, Epler GR: Isoniazid-associated hepatitis in 114 patients. Gastroenterology 1975; 69:289-302
7. Garibaldi RA, Drusin RE, Ferebee SH, Gregg MD: Isoniazid-associated hepatitis - Report of an outbreak. Am Rev Respir Dis 1972; 106:357-365
8. Kopanoff DE, Snider DE Jr, Caras GJ: Isoniazid-related hepatitis: A US Public Health Service cooperative surveillance study. Am Rev Respir Dis 1978; 117:991-1001
9. International Union Against Tuberculosis: Efficacy of various durations of isoniazid preventive therapy for tuberculosis: Five years of follow-up in the IUAT trial. Bull WHO 1982; 60:555-564
10. American Thoracic Society: Preventive treatment in tuberculosis - A statement by the committee on therapy. Am Rev Respir Dis 1965; 91:297-298
11. American Thoracic Society: Chemoprophylaxis for the prevention of tuberculosis. Am Rev Respir Dis 1967; 96:558-560
12. American Thoracic Society: Preventive treatment of tuberculosis. Am Rev Respir Dis 1971; 104:460-465
13. American Thoracic Society: Chemoprophylaxis for the prevention of tuberculosis - A statement by an ad hoc committee. Am Rev Respir Dis 1972; 106:357-365
14. American Thoracic Society: Preventive therapy of tuberculosis infection. Am Rev Respir Dis 1974; 110:311-314
15. American Thoracic Society: Treatment of tuberculosis and other mycobacterial diseases. Am Rev Respir Dis 1983; 127:790-796
16. American Thoracic Society: Treatment of tuberculosis and tuberculosis infection in adults and children. Am Rev Respir Dis 1986; 134:355-363
17. Centers for Disease Control and Prevention (CDC) Advisory Committee for the Elimination of Tuberculosis: The use of preventive therapy for tuberculous infection in the United States. MMWR 1990; 39(RR-8):9-12
18. CDC: A strategic plan for the elimination of tuberculosis in the United States. MMWR 1989; 38(suppl S-3):1-21
19. CDC: National action plan to combat multidrug-resistant tuberculosis. MMWR 1992; 41(RR-11):5-48
20. CDC: Update: tuberculosis elimination - United States. MMWR 1990; 39:153-156
21. Selwyn PA, Sckell BM, Alcabes P, Friedland GH, Klein RS, Schoenbaum EE: High risk of active tuberculosis in HIV-infected drug users with cutaneous anergy. JAMA 1992; 268:504-509
22. Moulding TS, Redeker AG, Kanel GC: Twenty isoniazid-related deaths in one state. Am Rev Respir Dis 1989; 140:700-705
23. Israel HL, Gottlieb JE, Maddrey WC: Perspective: Preventive isoniazid therapy and the liver. Chest 1992; 101:1298-1301
24. CDC: Severe isoniazid-associated hepatitis - New York, 1991-1993. MMWR 1993; 42:545-547
25. Tsevat J, Taylor WC, Wong JB, Pauker SG: Isoniazid for the tuberculin reactor: Take it or leave it. Am Rev Respir Dis 1988; 137:215-220
26. Moulding T, Barnes P: Isoniazid for the tuberculin reactor: Take it or leave it (Letter). Am Rev Respir Dis 1988; 138:488
27. Iseman MD, Miller B: If a tree falls in the middle of the forest. Am Rev Respir Dis 1989; 140:575-576
28. Snider DE Jr, Caras GJ: Isoniazid-associated hepatitis deaths: A review of available information. Am Rev Respir Dis 1992; 145:494-497
29. Salpeter SR: Fatal isoniazid-induced hepatitis - Its risk during chemoprophylaxis. West J Med 1993; 159:560-564
30. Levin ML, Moodie AS: Isoniazid prophylaxis and deaths in Baltimore, 1972. MD State Med J 1974; 23:64-67
31. Franks AL, Binkin NJ, Snider DE Jr, Rokaw WM, Becker S: Isoniazid hepatitis among pregnant and postpartum Hispanic patients. Public Health Rep 1989; 104:151-155
32. Gal AA, Klatt EC: Fatal isoniazid hepatitis in a child. Pediatr Infect Dis 1986; 5:490-491
33. Moulding TS, Redeker AG, Kanel GC: Acetaminophen, isoniazid, and hepatic toxicity (Letter). Ann Intern Med 1991; 114:431
34. Vanderhoof JA, Ament ME: Fatal hepatic necrosis due to isoniazid chemoprophylaxis in a 15 year-old girl. J Pediatr 1976; 88:867-868
35. Comstock GW: Prevention of tuberculosis among tuberculin reactors: Maximizing benefits, minimizing risks. JAMA 1986; 256:2729-2730
36. Rose DN, Schechter CB, Silver AL: The age threshold for isoniazid chemoprophylaxis - A decision analysis for low-risk tuberculin reactors. JAMA 1986; 256:2709-2713